Final Diagnosis -- Cerebral angiosarcoma


DIAGNOSIS   Cerebral angiosarcoma.

DISCUSSION

Angiosarcoma is a rare tumor accounting for less than one percent of all sarcomas (15). It occurs typically in the skin and soft tissues of the head and neck. It is a very malignant neoplastic proliferation arising from vascular endothelial cells. Systemic metastasis at the time of diagnosis is reported to be as high as 80% (8). Central nervous system (CNS) involvement has been described, but is quite unusual. Only 17 cases of cerebral angiosarcoma primary to the CNS have been reported in the English literature (9, 10). It occurs principally in the cerebral hemisphere with a predisposition for the parietal lobe. The mean age at diagnosis is 38 years and it shows a slight male predominance (66.7%). Cerebral metastases are also rare; only 21 cases have been described (1,3,5,6,8,9,11,14). The typical primary site for metastatic cerebral angiosarcoma is the heart, accounting for 57% of cases. Other primary sites have been described, such as Dacron aortic vascular grafts, aorta, pleura, skin, liver, penis, bone, placenta and the orbit. Cerebral metastases are multiple in 57.9% of the cases. There is a male predominance and the mean age is 42.2 years. The described risk factors for the development of angiosarcomas are radiation therapy, foreign object (12), chronic lymphedema associated with radical mastectomy, A-V fistulas and certain environmental carcinogens like vinyl chloride, arsenic and Thorotrast.

In a series of 53 post-radiation sarcomas (7), Laskin and al. reported that the most frequent radiation-induced sarcoma was malignant fibrous histiocytoma (68%) and that an angiosarcoma represented only one case (2%), on the thoracic wall. Another series (13) of 2500 patients treated for ENT cancer reported only 5 sarcomas in the irradiated zone. None were angiosarcoma.

Vascular prostheses, especially Dacron prostheses, also have the potential to induce malignant mesenchymatous changes (2,4,11,16). We, however, did not find any cases that occurred after insertion of a vascular endoprosthesis.

The histologic examination of this case shows typical features of angiosarcoma: atypical cells forming an irregular vascular network. The positivity of these cells for endothelial markers confirms the diagnosis. Immunohistochemistry for factor VIII was slightly positive but cases with poorly differentiated tumors are reported with equivocal positivity for this marker.

We believe this patient had an angiosarcoma of the carotid artery with distal tumor embolisms since all the lesions were restricted to this vascular territory, and presented as stroke-like episodes. The carotid stent might have contributed to the development of the tumor in tissues already sensitized by the prior irradiation. The brain tumors may also be primary angiosarcomas, but in view of the multiplicity of the lesions and the restriction to the vascular territory of the left internal carotid artery, this hypothesis seems less likely. Investigations did not reveal any other possible primary source. Unfortunately, even though a mass of tumoral cells was identified inside one of the specimen's vascular channels, we are not able to ascertain that the primary site is the carotid artery, as the family of the patient refused the proposed autopsy.

REFERENCES

  1. Akutsu H, Tsuboi K, Sakamoto N, Nose T, Honma S, Jikuya T (2004) Cerebral metastasis from angiosarcoma of the aortic wall: Case report. Surg Neurol 61:68-71.
  2. Ben-Izhak O, Vlodavsky E, Ofer A, Engel A, Nitecky S, Hoffman A (1999) Epithelioid angiosarcoma associated with a Dacron vascular graft. Am J Surg Pathol 23(11):1418-1422.
  3. Ellegala DB, Kligora C, Vandenberg S, Dumont A, Shaffrey ME (2002) Intracranial metastasis of a primary scalp angiosarcoma: case illustration. J Neurosurg 97:725.
  4. Fehrenbacher JW, Bowers W, Strate R, Pittman J (1981) Angiosarcoma of the aorta associated with a Dacron graft. Ann Thorac Surg 32(3):297-301.
  5. Hosni FA, Iskander SG (1967) Orbital angiosarcoma with intracranial metastasis. Eye Ear Nose Throat Mon 46(10):1265-1269.
  6. Kimura M, Ito H, Furuta T, Tsumoto T, Hayashi S (2003) Pyothorax-associated angiosarcoma of the pleura with metastasis to the brain. Pathol Int 53:547-551.
  7. Laskin WB, Silverman TA, Enzinger FM (1988) Postradiation soft tissue sarcomas, an analysis of 53 cases. Cancer 62:2330-2340.
  8. Liassides C, Katsamaga M, Deretzi G, Koutsimanis V, Zacharakis G (2004) Cerebral metastasis from heart angiosarcoma presenting as multiple hematoma. J Neuroimaging 14(1):71-73.
  9. Matsuno A, Nagashima T, Tajima Y, Sugano I (2005) A diagnostic pitfall: Angiosarcoma of the brain mimicking cavernous angioma. J Clin Neurosci 12(6):688-691.
  10. Mena H, Ribas JL, Enzinger FM, Parisi JE (1991) Primary angiosarcoma of the central nervous system. J of Neurosurg 75:73-76.
  11. Okada M, Takeuchi E, Mori Y, Ichihara S, Usui A, Ueda Y (2004) An autopsy case of angiosarcoma arising around a woven Dacron prosthesis after a Cabrol operation. J Thorac Cardiovasc Surg 127(6):1843-1845.
  12. Oppenheimer BS, Oppenheimer ET, Stout AR (1948) Sarcomas induced in rats by implanting cellophane. Proc Soc Exper Biol Med 67:33-34.
  13. Van der Laan BF, Baris G, Gregor RT, Hilgers FJ, Balm AJ (1995) Radiation induced tumors of the head and neck. J Laryngol Otol 109:346-349.
  14. Vaquero J, Martinez R, Coca S, Oya S, Burgos R (1990) Cerebral metastasis from angiosarcoma of the heart: Case report. J of Neurosurg 73:633-635.
  15. Weiss SW, Goldblum JR (1995) Malignant Vascular Tumors. In: Soft Tissue Tumors, chapter 25, pp. 917-938, Mosby: London.
  16. Weiss WM, Riles TS, Gouge TH, Mizrachi HH (1991) Angiosarcoma at the site of a Dacron vascular prosthesis: a case report and literature review. J Vasc Surg 14(1):87-91.

Contributed by Nicolas Dea MD; Manuela Pelmus MD; David Mathieu MD; François Belzile MD; Denis Bergeron MD; Sylvie Gosselin MD; Ana-Maria Tsanaclis MD




Case IndexCME Case StudiesFeedbackHome